Universal DX

Healthcare & Life Sciences

Recent Finacing

Series B

Recent Raise

Undisclosed

Universal DX (UDX) is a biotech company developing a blood test for early detection of colorectal cancer using next-generation sequencing and bioinformatics.

Total Funding

Undisclosed

Headquarters

Cambridge, USA

Founded

N/A

Website

universaldx.com

Focus Areas

biotech

colorectal cancer

blood test

clinical trial

FDA approval

next-generation sequencing

Investors